AskNiveshClosed·16:29 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to AJANTPHARM

Ajanta Pharmaceuticals Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
1,1701,3031,3541,3751,422
Other income
1826592561
Expenses
9199981,0721,0411,136
Cost of materials consumed
191207218235257
Purchases of stock-in-trade
8052535471
Change in inventories
121746-2-23
Employee benefit expense
280303317331341
Finance costs
65352
Depreciation & amortisation
4041434445
Other expenses
310373392376443
EBITDA
315378387408395
EBIT
275336344364349
Profit Before Tax
269331341359347
Tax expense
4476818580
Deferred tax
-1822-219
Net Profit
225255260274267
Financial Ratios
Operating Profit Margin
23.51%25.81%25.44%26.48%24.57%
EBITDA Margin
26.91%28.98%28.61%29.64%27.76%
Net Profit Margin
19.23%19.57%19.20%19.93%18.78%
Earnings Per Share (₹)
18.0020.4420.8321.9121.35

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.